US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

ENTA Enanta Pharmaceuticals Inc

12.21

-0.04 (-0.33%)

26 Jun 2024 - Cerrado

Retrasado por 15 minutos

Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individuals

Enanta Pharmaceuticals (NASDAQ:ENTA)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Haga Click aquí para más Gráficas Enanta Pharmaceuticals.

Enanta Pharmaceuticals (NASDAQ:ENTA)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024

Haga Click aquí para más Gráficas Enanta Pharmaceuticals.

Noticias sobre Enanta Pharmaceuticals Inc ENTA

Form 4 - Statement of changes in beneficial ownership of securities
Lunes 17 de Junio 2024 (1 semana hace) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Lunes 17 de Junio 2024 (1 semana hace) • Edgar (US Regulatory)

Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference
Miércoles 29 de Mayo 2024 (4 semanas hace) • Business Wire

Form S-8 - Securities to be offered to employees in employee benefit plans
Miércoles 8 de Mayo 2024 (2 meses hace) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Miércoles 8 de Mayo 2024 (2 meses hace) • Edgar (US Regulatory)

Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference
Martes 7 de Mayo 2024 (2 meses hace) • Business Wire

Form 8-K - Current report
Lunes 6 de Mayo 2024 (2 meses hace) • Edgar (US Regulatory)

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET
Lunes 6 de Mayo 2024 (2 meses hace) • Business Wire

Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Martes 30 de Abril 2024 (2 meses hace) • Business Wire

Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
Martes 30 de Abril 2024 (2 meses hace) • Business Wire

Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
Lunes 29 de Abril 2024 (2 meses hace) • Business Wire

Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
Miércoles 17 de Abril 2024 (2 meses hace) • Business Wire

Más de Enanta Pharmaceuticals Inc Artículos de Noticias

Gold vs US Dollar

Bank of America

BNP Paribas (QX)

Verizon Communications

Financial Select Sector

Euro vs US Dollar

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones